Total β-adrenoceptor deficiency results in cardiac hypotrophy and negative inotropy

Physiological Research

Volumn 59, Issue 5, 2010, Pages 679-689

  Lee, S ^a   Grafweg, S ^a   Schneider, T ^a   Jimenez, M ^b   Giacobino, J P ^b   Ghanem, A ^c   Tiemann, K ^d   Bloch, W ^d   Muller Ehmsen J ^a   Schwinger, R H G ^f   Brixius, K ^a,e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^f Medical Clinic II   (Germany)

Author keywords

Beta 1 adrenoceptor; Beta 2 adrenoceptor; Beta 3 adrenoceptor; Knockout; Mice

Indexed keywords

ATP2A2 PROTEIN, MOUSE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CARDIOMEGALY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; GENETICS; HEART CONTRACTION; METABOLISM; MOUSE; MOUSE MUTANT; MUSCLE FIBRIL; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CARDIOMEGALY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ECHOCARDIOGRAPHY; FEMALE; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOFIBRILS; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-CALCIUM EXCHANGER;

EID: 78649756229     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. BACHMAN ES, DHILLON H, ZHANG CY, CINTI S, BIANCO AC, KOBILKA BK, LOWELL BB: (AR signaling required for diet-induced thermogenesis and obesity resistance. Science 297: 843-845, 2002.
2. BACHMAN ES, HAMPTON TG, DHILLON H, AMENDE I, WANG J, MORGAN JP, HOLLENBERG AN: The metabolic and cardiovascular effects of hyperthyroidism are largely independent of beta-adrenergic stimulation. Endocrinology 145: 2767-2774, 2004.
3. BERNSTEIN D: Exercise assessment of transgenic models of human cardiovascular disease. Physiol Genomics 13: 217-226, 2003.
4. BERS DM: Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. BRADFORD MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
6. 2+/calmodulin-dependent protein kinase II-protein phosphatase 1 switch facilitates specificity in postsynaptic calcium signaling. Proc Natl Acad Sci U S A 100: 10512-10517, 2003.
7. BRIXIUS K, BLOCH W, POTT C, NAPP A, KRAHWINKEL A, ZISKOVEN C, KORILLER M, MEHLHORN U, HESCHELER J, FLEISCHMANN B, SCHWINGER RH: Mechanisms of β3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol 143: 1014-1022, 2004.
8. 2+-sensitivity of myofibrillar tension in heart failure and its functional implication. Basic Res Cardiol 97 (Suppl 1): I111-I117, 2002.
9. BRIXIUS K, SCHWINGER RH: Modulation of cross-bridge interaction by 2,3-butanedione monoxime in human ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 361: 440-444, 2000.
10. CHRUSCINSKI AJ, ROHRER DK, SCHAUBLE E, DESAI KH, BERNSTEIN D, KOBILKA BK: Targeted disruption of the β2 adrenergic receptor gene. J Biol Chem 274: 16694-16700, 1999.
11. CHU A, DIXON MC, SAITO A, SEILER S, FLEISCHER S: Isolation of sarcoplasmic reticulum fractions referable to longitudinal tubules and junctional terminal cisternae from rabbit skeletal muscle. Methods Enzymol 157: 36-46, 1988.
12. 2+-handling in failing human myocardium. J Mol Cell Cardiol 33: 1345-1353, 2001.
13. DU XJ, GAO XM, WANG B, JENNINGS GL, WOODCOCK EA, DART AM: Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing β2-adrenergic receptors in the heart. Cardiovasc Res 48: 448-454, 2000.
14. ENGELHARDT S, HEIN L, WIESMANN F, LOHSE MJ: Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 96: 7059-7064, 1999.
15. FABIATO A, FABIATO F: Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) 75: 463-505, 1979.
16. 2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 57: 20-27, 2003.
17. GAUTHIER C, LEBLAIS V, KOBZIK L, TROCHU JN, KHANDOUDI N, BRIL A, BALLIGAND JL, LE MAREC H: The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102: 1377-1384, 1998.
18. GAUTHIER C, TAVERNIER G, CHARPENTIER F, LANGIN D, LE MAREC H: Functional β3-adrenoceptor in the human heart. J Clin Invest 98: 556-562, 1996.
19. GHANEM A, ROLL W, HASHEMI T, DEWALD O, DJOUFACK PC, FINK KB, SCHRICKEL J, LEWALTER T, LUDERITZ B, TIEMANN K: Echocardiographic assessment of left ventricular mass in neonatal and adult mice: accuracy of different echocardiographic methods. Echocardiography 23: 900-907, 2006.
20. GUTH K, WOJCIECHOWSKI R: Perfusion cuvette for the simultaneous measurement of mechanical, optical and energetic parameters of skinned muscle fibres. Pflugers Arch 407: 552-557, 1986.
21. JIMENEZ M, LEGER B, CANOLA K, LEHR L, ARBOIT P, SEYDOUX J, RUSSELL AP, GIACOBINO JP, MUZZIN P, PREITNER F: β1/β2/β3-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting. FEBS Lett 530: 37-40, 2002.
22. KIRIAZIS H, WANG K, XU Q, GAO XM, MING Z, SU Y, MOORE XL, LAMBERT G, GIBBS ME, DART AM, DU XJ: Knockout of β1- and β2-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis. Br J Pharmacol 153: 684-692, 2008.
23. KOHOUT TA, TAKAOKA H, MCDONALD PH, PERRY SJ, MAO L, LEFKOWITZ RJ, ROCKMAN HA: Augmentation of cardiac contractility mediated by the human β3-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104: 2485-2491, 2001.
24. KRANIAS EG, SOLARO RJ: Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature 298: 182-184, 1982.
25. LEE S, SCHWINGER RH, BRIXIUS K: Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors - what can we learn for the therapy of heart failure? Pflugers Arch 455: 767-774, 2008
26. MACLELLAN WR, SCHNEIDER MD: Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 62: 289-319, 2000.
27. MACLENNAN DH, KRANIAS EG: Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577, 2003.
28. MATTIAZZI A, MUNDINA-WEILENMANN C, GUOXIANG C, VITTONE L, KRANIAS E: Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 68: 366-375, 2005.
29. 2+, adenine nucleotide, and calmodulin. J Biol Chem 262: 3065-3073, 1987.
30. MONIOTTE S, KOBZIK L, FERON O, TROCHU JN, GAUTHIER C, BALLIGAND JL: Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103: 1649-1655, 2001.
31. 2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium. J Mol Med 76: 434-441, 1998.
32. MUNDINA-WEILENMANN C, VITTONE L, ORTALE M, DE CINGOLANI GC, MATTIAZZI A: Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol Chem 271: 33561-33567, 1996.
33. ROHRER DK, CHRUSCINSKI A, SCHAUBLE EH, BERNSTEIN D, KOBILKA BK: Cardiovascular and metabolic alterations in mice lacking both (1- and (2-adrenergic receptors. J Biol Chem 274: 16701-16708, 1999.
34. ROHRER DK, DESAI KH, JASPER JR, STEVENS ME, REGULA DP Jr, BARSH GS, BERNSTEIN D, KOBILKA BK: Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci USA 93: 7375-7380, 1996.
35. ROHRER DK, SCHAUBLE EH, DESAI KH, KOBILKA BK, BERNSTEIN D: Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse. Am J Physiol 274: H1184-H1193, 1998.
36. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
37. SITSAPESAN R, WILLIAMS AJ: Mechanisms of caffeine activation of single calcium-release channels of sheep cardiac sarcoplasmic reticulum. J Physiol Lond 423: 425-439, 1990.
38. TIEMANN K, WEYER D, DJOUFACK PC, GHANEM A, LEWALTER T, DREINER U, MEYER R, GROHE C, FINK KB: Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Am J Physiol 284: H464-H474, 2003.
39. 2+ sensitivity of the contractile apparatus in endstage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57: 37-47, 2003.
40. VARGHESE P, HARRISON RW, LOFTHOUSE RA, GEORGAKOPOULOS D, BERKOWITZ DE, HARE JM: β3-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J Clin Invest 106: 697-703, 2000.
41. WALLUKAT G: The beta-adrenergic receptors. Herz 27: 683-690, 2002.
42. 2+ handling in heart failure. J Clin Invest 115: 556-564, 2005.